CASE OF THE MONTH: February 1999 - 54 year old man with severe muscle weakness

Michael D. Hill; Juan M. Bilbao

doi:10.1111/j.1750-3639.1999.tb00607.x

CASE OF THE MONTH: February 1999 - 54 year old man with severe muscle weakness

Michael D. Hill^*
, Juan M. Bilbao

^*Autor correspondiente de este trabajo

University of Toronto

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

14 Citas (Scopus)

Resumen

A 54 year old man developed rhabdomyolysis one year after beginning treatment with a combination of lorastatin (an HMGCoA reductase inhibitor) and niacin. Muscle biopsy showed a severe necrotizing myopathy affecting both fibre types. Recovery occurred gradually with cessation of medication. The spectrum of cholesterol lowering agent myopathy may include delayed cases of unusual severity.

Idioma original	Inglés
Páginas (desde-hasta)	607-608
Número de páginas	2
Publicación	Brain Pathology
Volumen	9
N.º	3
DOI	https://doi.org/10.1111/j.1750-3639.1999.tb00607.x
Estado	Publicada - jul. 1999
Publicado de forma externa	Sí

Acceder al documento

10.1111/j.1750-3639.1999.tb00607.x

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{4ebf801450574d77a3355e4d296e31dd,

title = "CASE OF THE MONTH: February 1999 - 54 year old man with severe muscle weakness",

abstract = "A 54 year old man developed rhabdomyolysis one year after beginning treatment with a combination of lorastatin (an HMGCoA reductase inhibitor) and niacin. Muscle biopsy showed a severe necrotizing myopathy affecting both fibre types. Recovery occurred gradually with cessation of medication. The spectrum of cholesterol lowering agent myopathy may include delayed cases of unusual severity.",

author = "Hill, \{Michael D.\} and Bilbao, \{Juan M.\}",

year = "1999",

month = jul,

doi = "10.1111/j.1750-3639.1999.tb00607.x",

language = "Ingl{\'e}s",

volume = "9",

pages = "607--608",

journal = "Brain Pathology",

issn = "1015-6305",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - CASE OF THE MONTH

T2 - February 1999 - 54 year old man with severe muscle weakness

AU - Hill, Michael D.

AU - Bilbao, Juan M.

PY - 1999/7

Y1 - 1999/7

N2 - A 54 year old man developed rhabdomyolysis one year after beginning treatment with a combination of lorastatin (an HMGCoA reductase inhibitor) and niacin. Muscle biopsy showed a severe necrotizing myopathy affecting both fibre types. Recovery occurred gradually with cessation of medication. The spectrum of cholesterol lowering agent myopathy may include delayed cases of unusual severity.

AB - A 54 year old man developed rhabdomyolysis one year after beginning treatment with a combination of lorastatin (an HMGCoA reductase inhibitor) and niacin. Muscle biopsy showed a severe necrotizing myopathy affecting both fibre types. Recovery occurred gradually with cessation of medication. The spectrum of cholesterol lowering agent myopathy may include delayed cases of unusual severity.

UR - https://www.scopus.com/pages/publications/0033051851

U2 - 10.1111/j.1750-3639.1999.tb00607.x

DO - 10.1111/j.1750-3639.1999.tb00607.x

M3 - Artículo

C2 - 10416996

AN - SCOPUS:0033051851

SN - 1015-6305

VL - 9

SP - 607

EP - 608

JO - Brain Pathology

JF - Brain Pathology

IS - 3

ER -

CASE OF THE MONTH: February 1999 - 54 year old man with severe muscle weakness

Resumen

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto